From: "Eesti Optometristide Selts" <info@optometristid.ee>
To: "Info - SOM" <info@sm.ee>,
	"Liina Tarum" <liina@nagemisuuringud.ee>
Subject: =?utf-8?Q?Sotsiaalkaitseministri_m=C3=A4=C3=A4rus_nr?=
	=?utf-8?Q?_74_eeln=C3=B5u_=28abivahendite_loetelu?=
	=?utf-8?Q?=29_tagasiside?=
Date: Tue, 25 Aug 2026 09:31:12 +0300
Keywords: ly
Message-ID: <662482572.384731.1787639472979@oxapp.veebimajutus.ee>
MIME-Version: 1.0
Content-Type: multipart/alternative;
	boundary="----=_NextPart_000_0037_01DD3474.D151C2B0"
Thread-Index: AQFTJTbZJUHHq4rt/7Dyc0EhT3DxDA==
X-MS-Exchange-Transport-CrossTenantHeadersStamped: DU4PR02MB11668
X-MS-Exchange-Organization-ExpirationStartTime: 25 Aug 2026 06:31:20.8179
 (UTC)
X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit
X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000
X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit
X-MS-Exchange-Organization-Network-Message-Id: b2aacbda-7b2f-43fa-7a79-08df02727a1d
X-EOPAttributedMessage: 0
X-MS-Exchange-Organization-MessageDirectionality: Incoming
X-MS-Exchange-Organization-AuthAs: Anonymous
X-MS-Exchange-Organization-AuthSource: AMS1EPF0000004A.eurprd04.prod.outlook.com
X-MS-Exchange-Organization-SCL: -1
X-MS-PublicTrafficType: Email
X-Microsoft-Antispam: BCL:0;ARA:13230040|704161411799003|82310400026|2069299003|5009299003|55112099003|16102099003|18002099003|11063799006|56012099006|5063699009|8096899003|19002099009|10067099003;
X-Forefront-Antispam-Report: CIP:213.184.53.4;CTRY:EE;LANG:et;SCL:-1;SRV:;IPV:CAL;SFV:NSPM;H:mail1.rit.ee;PTR:mail1.rit.ee;CAT:NONE;SFS:(13230040)(704161411799003)(82310400026)(2069299003)(5009299003)(55112099003)(16102099003)(18002099003)(11063799006)(56012099006)(5063699009)(8096899003)(19002099009)(10067099003);DIR:INB;
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 25 Aug 2026 06:31:20.6090
 (UTC)
X-MS-Exchange-CrossTenant-Network-Message-Id: b2aacbda-7b2f-43fa-7a79-08df02727a1d
X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2
X-MS-Exchange-CrossTenant-AuthAs: Anonymous
X-MS-Exchange-CrossTenant-AuthSource: AMS1EPF0000004A.eurprd04.prod.outlook.com
X-MS-Exchange-CrossTenant-FromEntityHeader: Internet
X-MS-Exchange-Transport-EndToEndLatency: 00:00:04.0653063
X-MS-Exchange-Processed-By-BccFoldering: 15.21.0339.010
X-MS-Exchange-ExternalInOutlookResult: NotEnabled
X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(4710232)(4717077)(4999285)(920097)(930201)(20251009189)(140003);
X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?CT0jS12fpr5w0GhGaAXVnL1YtCdbOFBLynpQx6IRA8oSVh0OvLRgR7OajuUy?=
 =?us-ascii?Q?pkK8LF6up5TKyjiocqbFRmSge+17BXz4RyoaVbdvjFxS2d8M/QpLHMPlgSxL?=
 =?us-ascii?Q?9EtL/hyAIeIkt5benVI0kBHxsevX2wL7aYGI54QjbLxp67erM2HLeml9sLUt?=
 =?us-ascii?Q?VGK8xpFOrz2qDv8ZdCOFJA7/AgJMizyuKDlVWZX0h47zzQ64weUIMrkBEVrZ?=
 =?us-ascii?Q?7+63eosdEkaHUGctsq/K+RzQMBQDRlJMC65qHHW+B4i7b3564iG+JxgBSlqI?=
 =?us-ascii?Q?n3SJucBNs5cLQ36ssmQMrYS810b7lzXLhx5nKDYs3tEeTKrV68i64m2y7L1d?=
 =?us-ascii?Q?3M4L/85lDy5kRIX4mQPRMp9yee7X7K1njGNjA5Cr0oPRK2wqEK3AYgnvw20A?=
 =?us-ascii?Q?tEHsIK8K5PXZLDbZackMHZiyF+arg6PG/dZh1UOg3u0MZahf/ozCEoBYGFzm?=
 =?us-ascii?Q?EqjHJVzwo7f+PeJ1TUDwSpooCuhe/b9jImHiCB3kOpYZSgAP3BzWkX9A1LT5?=
 =?us-ascii?Q?8ElMe5aeD8Kk3ssbBIoWLT8EiFbEsL0JVmGgGKtehUvxs3gAVP1w84uVzuBR?=
 =?us-ascii?Q?MhreRBMfDyAp6gwCS0a80yN9B2JZzRE6IK8TWWxN6OKH2eiNu4ng4rXic++u?=
 =?us-ascii?Q?bwTt/QvJ1hrKN9HzY5G/mYalGKPN9iGfUYukPJtK/xI+OvBcKBZYkZYdY5iQ?=
 =?us-ascii?Q?YsP1lra1lnI8dFUKGn9vnIhDoAIAADslSFd+mpv1z9FcNEqs7A+
	KhHlzx8t+?=
 =?us-ascii?Q?kpUGJLuMLfpIDhVe2YbHaoGSHR5TJQayqDp7BIL8IOpV8TGtcc6CSEpQI/Er?=
 =?us-ascii?Q?J153QuDwVSeMZY50XmnNl/JGsRnRuK8sHJkvpdGWvOcnQVYM5XB5eUKrB0HJ?=
 =?us-ascii?Q?CnphcvwHUqAyMhSd+Go29Jndjiuxl6siWiFyyBO1GO9kb172SUMs0g6zEahU?=
 =?us-ascii?Q?ukbzIJthSzYUwVv0E8jUXuFj/lyssEEwwfqGpZJ6q3R4pXih6ROnpERl0/mg?=
 =?us-ascii?Q?QWu+lGCgsbUPt+/50mq/BrUrOaxjB7yrox++aS+IPlOKfTQbbNCD7sNQHz9l?=
 =?us-ascii?Q?dUqcOVbLxpNKkzpv+RgEsZe3vehySeKA6kXokSkiFWaIJeeGBAX/RYCb4Mn7?=
 =?us-ascii?Q?B+QjqkNAk9Dj1beo7aUEEkyDW2zReE4+2RiADdN6HuNAnQDH1NTDY4r1VKi0?=
 =?us-ascii?Q?XDYBtu3IehkA/22b8CWC6NfuYxVQMJkt3ubvEzdKv7MjBd1QaXqsat5btW0U?=
 =?us-ascii?Q?VMvNXi+Rjl6QhSzB6ff5ZaZwnXPjuWrBcTgFqTmy9eqN7AieUehNEi659eCK?=
 =?us-ascii?Q?NbZrttfYKPqwoio0cyquTBlGHGDaK6aqq3BJL4I33U7Duqhi/sah9gdrPfw8?=
 =?us-ascii?Q?8/QlTYFcWTZUcuELltjdKB1rzLB6GipIQZcGhY/+nCva6BixSiD7RiTWUKv6?=
 =?us-ascii?Q?on0ZcokdesGDMNfw/7ciucKJMJjRoBRkkAAA0saDsKA4P3cqUw3RfaD8NWTF?=
 =?us-ascii?Q?e6eU4wn+W21bbLUoS3KWKgqgIvBdPE3/UD4CC
	X60fRNam33MLCURwLJJKn6J?=
 =?us-ascii?Q?dZxud5f8I6hu8wclNhKvrzn4LxZRfpqE/T2Z9irP52yNoIcnsSWdKHHeK6d7?=
 =?us-ascii?Q?HOSd+ow0Hu4LO+JmiAU3bC6gRwSkW83C15nbNFnDpRb9eBWT8B277hQ+1B1a?=
 =?us-ascii?Q?CpKBbne+BlaxMEp420n4OmqKl31gBJuu4ClHYgVDdsUQ2S1TVbikv2I393Vi?=
 =?us-ascii?Q?rnjqlEvvdvt6J7IShbeLWY57jh1mccwZqnWKtFRl9WDJ5ipAHyFNJ4uRtaUf?=
 =?us-ascii?Q?FrWq6+HKCg6x/RWtUCxwFA/sSLFcQcv1KcEzlm5YY3BNBa49stZRE3LINtqf?=
 =?us-ascii?Q?3Hvor0KV4Gbev9ZoWWUh8Pt6Y4lWKs5jq6Tnkkm76KFVhkcQda7P57dvW2cK?=
 =?us-ascii?Q?SmGOzoZ53+XzXITozVmum9njD0g3uyy0KhP9Of47FbyJmXDzwvGUEmzZ47LM?=
 =?us-ascii?Q?c3CkyS2AzG5rd5TmGU0/8Ec09Qj0yFSyuFJx4Dq/WbBkuOvBbLgZ9nVOoaWr?=
 =?us-ascii?Q?Hf7kqms4qVusYy68ujYYKnWcHoSylPNKFkNW9obvB2/AE5vJ6oFfh+okZVLj?=
 =?us-ascii?Q?eZQMwMkUo3aC1Hhz7A9lRWsfYNMSr5jUk/6DvkKifdbsi3xxaz0L+QBHTb8r?=
 =?us-ascii?Q?LqwfN/KszLlKYGzusCjs1EiuaOIXCr7OVFSx7Ca/8zz8jjKCr+nhGYplm06S?=
 =?us-ascii?Q?MIJbGsEPEJ4r3i4SJUGKzKKc2rWS6/nmJ1o6BaFQkO2wReFXvdR1//pMMjG5?=
 =?us-ascii?Q?QOasBICcvUhyhFziuQOynEy
	MrjhO2smQTrMk2UFvFPFqsWMA4OHtDehlWMMA?=
 =?us-ascii?Q?9JKgRIIm/HmC/uuyH9uCyAPFhg3hZ1y4TcARcrrf2Cn66HCjLcNgq5RI/7H7?=
 =?us-ascii?Q?NlzUJcn9PXDUwq2Bs9sjOXTcIngdNuz2+LNdm+ymfoAhw98/WJ0jsoq/hAjf?=
 =?us-ascii?Q?24cxwZm295jdOu3dCgO4q8iuB7TrNOi99aa8lEQPm0HBoVR5jPqEFBt3qSzG?=
 =?us-ascii?Q?/1hQ4L2ULL0P3pn9HaS5trVeVGVUt9p2tXle7j1Prk+IUitedQUWZ9mkqTLU?=
 =?us-ascii?Q?MTqS5mjL5ZA+TwdrQ/fEB97NT6eABidCbjp8ziYaKj8ovxjFVUkf8Fj/SuzM?=
 =?us-ascii?Q?Yx0t1rUhk7kJl2eQEzx7bXFlZoxYC1cioSzGr6e9rVItrVGeP/PG3BeRxfLZ?=
 =?us-ascii?Q?QLEUjr8jM+xUsnRo0zBzWBawCEmGH32pjur8HmMHkmU62jCUo8ep?=
Content-Language: en-us
received-spf: None (mail1.rit.ee: no sender authenticity  information available from domain of  postmaster@mail-out.elkdata.ee) identity=helo;  client-ip=85.194.200.224; receiver=mail1.rit.ee;  envelope-from="info@optometristid.ee";  x-sender="postmaster@mail-out.elkdata.ee";  x-conformance=spf_only
x-ms-exchange-organization-originalclientipaddress: 213.184.53.4
x-ms-exchange-organization-originalserveripaddress: 10.167.16.134
X-OlkEid: 0000000033F4068251E5764083FB7241D8AC8008070034AD76187591974DBF6C4F76951C873A0100020000000000EE036A86AA193F47AA713E32FE8F2E5700000000130E0000B29C1CAF48143641B0D363A0CDA256A6
X-CSE-ConnectionGUID: HPiujQLFRZWC5WpKfiVPvg==
X-CSE-MsgGUID: /kFmpEHhSV6vQNxdo9jkMg==
X-ThreatScanner-Verdict: Negative
X-IPAS-Result: =?us-ascii?q?A0GGBAANNo1qeeDIwlVahRqBbDAECxovhFiIeoollxSEC?=
 =?us-ascii?q?YNTDwEBAQEBAQxPAgQBAQMBA5JtIAcBSwECAQIBAwIDAQEBAQEBAQEBAQELA?=
 =?us-ascii?q?QEBBAEBAQIBAQIEAwEBAQECEAEBQkmGTw2CYgEzghYsgTQdAQEnARAUBAY+A?=
 =?us-ascii?q?l4BI4UUAlAHozycHYEygQGCDAEBBgQFAd4SCYZSg00MASqBNQEChAYQO4R9B?=
 =?us-ascii?q?kCBTYFKi1KCaoImehIbkzpIfCIDJjMsAVUTDQoLBwWBMzMDKgsSEhgKC24yH?=
 =?us-ascii?q?XAMJxIsFwgtWBsGBYEdgSiCfYETIxk2fIEJXoErKWESF4EJggcCglqBGQFrA?=
 =?us-ascii?q?gFJQw4HRyILGA1IESw3Bg4ZQm4HjXtiH6oHghsBi32VF4QoNQmhODOXX5MNk?=
 =?us-ascii?q?yuFXSOkNwSEZTaBSiKBXE04gyJQAxkPji0WhEzLMHY9AgIBBAIHAQsBAQMJA?=
 =?us-ascii?q?QGCOIJUNSYTjCKBTAEB?=
X-Talos-CUID: 9a23:M7C+aWOCAkbS+e5DeBFm6UwtPu4fQEL2kUjIAEG5N153R+jA
X-Talos-MUID: =?us-ascii?q?9a23=3A2niDwA9lXBQ52685FRr+3QSQf4BrzaG2JWANqqt?=
 =?us-ascii?q?YpfCiJSB3ajWeqTviFw=3D=3D?=
X-IronPort-Anti-Spam-Filtered: true
X-IronPort-AV: E=Sophos;i="6.25,242,1779138000"; 
   d="scan'208,217";a="78180686"
X-Amp-Result: SKIPPED(no attachment in message)
X-Amp-File-Uploaded: False
X-EOPTenantAttributedMessage: 8fe098d2-428d-4bd4-9803-7195fe96f0e2:0
X-DisclaimerOO: 1
dkim-signature: v=1; a=rsa-sha256; c=relaxed/simple; d=optometristid.ee;	s=mail-out; t=1787639477;	bh=RcwdSNeAVtwxw92QsfznrFLrHgNn9Upgm85cexJ3TaU=;	h=Date:From:To:Subject:From;	b=YaTQ/idlrX3HSz21TEVtj2L27rxJbhb4mjpAKJcYyOLB7Xf3iOmBJ/ElohWLS+gt9	 zIT+6jbGApc5upY5YTu0xb0JGoJSkm3OZzbji2AaITx2wnyjVFuTV0O1CaetPcD66/	 ZJXkHTyUUf1ZqFQ8LOgZpF0CzZtlmeXte1e7emmw=

This is a multipart message in MIME format.

------=_NextPart_000_0037_01DD3474.D151C2B0
Content-Type: text/plain;
	charset="utf-8"
Content-Transfer-Encoding: 8bit


Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.

Tere!

Täname võimaluse eest avaldada arvamust sotsiaalkaitseministri määruse nr 74 
muutmise eelnõu kohta.

Oleme eelnõu ja selle seletuskirjaga tutvunud. Optometristide ning optiliste 
abivahendite osas me eelnõus sisulisi muudatusi ei tuvastanud.

Soovime siiski täpsustust optiliste abivahendite piirhindade kohta. Palume 
selgitada, millistele andmetele tuginedes on leitud, et nende piirhindu ei 
ole vaja tõsta. Optiliste abivahendite ja prilliklaaside hinnad on viimastel 
aastatel suurenenud ning praegused piirhinnad ei pruugi enam võimaldada 
sobiva abivahendi soetamist piirhinna ulatuses.

Lisaks palume täpsustada, millise ISO-koodi alla kuuluvad optilised 
filterklaasid. Kas neid käsitletakse ISO-koodi 22.03.03 „valgusfiltrid“ all? 
Optilised filterklaasid kuuluvad praegu meie hinnakirjas kõige kallimate 
toodete hulka, mistõttu soovime teada, kas selle abivahendi kehtiv piirhind 
152 eurot paari kohta hõlmab ka individuaalselt valmistatavaid optilisi 
filterklaase.

Kui optilised filterklaasid kuuluvad nimetatud ISO-koodi alla, palume 
kaaluda ka selle piirhinna ajakohastamist vastavalt tegelikele 
turuhindadele.

Lugupidamisega

Liina Tarum-Maisla
Eesti Optometristide Selts
55572374

------=_NextPart_000_0037_01DD3474.D151C2B0
Content-Type: text/html;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

<!doctype html><html><head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; =
charset=3Dutf-8">
</head>
<body>
<table class=3D"MsoNormalTable" border=3D"0" cellspacing=3D"0" =
cellpadding=3D"0" align=3D"left" width=3D"100%" =
style=3D"width:100.0%;mso-cellspacing:0cm;mso-yfti-tbllook:1184; =
mso-table-lspace:2.25pt;mso-table-rspace:2.25pt;mso-table-anchor-vertical=
:paragraph;mso-table-anchor-horizontal:column;mso-table-left:left;mso-pad=
ding-alt:0cm 0cm 0cm 0cm">
<tbody>
<tr =
style=3D"mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes">
<td style=3D"background:#910A19;padding:5.25pt 1.5pt 5.25pt 1.5pt"></td>
<td width=3D"100%" =
style=3D"width:100.0%;background:#FDF2F4;padding:5.25pt 3.75pt 5.25pt =
11.25pt; word-wrap:break-word" cellpadding=3D"7px 5px 7px 15px" =
color=3D"#212121">
<div>
<p class=3D"MsoNormal" =
style=3D"mso-element:frame;mso-element-frame-hspace:2.25pt; =
mso-element-wrap:around;mso-element-anchor-vertical:paragraph;mso-element=
-anchor-horizontal: column;mso-height-rule:exactly">
<span style=3D"font-size:9.0pt;font-family: &quot;Segoe =
UI&quot;,sans-serif;mso-fareast-font-family:&quot;Times New =
Roman&quot;;color:#212121"><strong>T=C3=A4helepanu!
</strong>Tegemist on v=C3=A4lisv=C3=B5rgust saabunud kirjaga.<br>
Tundmatu saatja korral palume linke ja faile mitte =
avada.<o:p></o:p></span></p>
</div>
</td>
</tr>
</tbody>
</table>
<div>
<div class=3D"default-style">
<div>Tere!</div>
<div>&nbsp;</div>
<div>T=C3=A4name v=C3=B5imaluse eest avaldada arvamust =
sotsiaalkaitseministri m=C3=A4=C3=A4ruse nr 74 muutmise eeln=C3=B5u =
kohta.</div>
<div>&nbsp;</div>
<div>Oleme eeln=C3=B5u ja selle seletuskirjaga tutvunud. Optometristide =
ning optiliste abivahendite osas me eeln=C3=B5us sisulisi muudatusi ei =
tuvastanud.</div>
<div>&nbsp;</div>
<div>Soovime siiski t=C3=A4psustust optiliste abivahendite piirhindade =
kohta. Palume selgitada, millistele andmetele tuginedes on leitud, et =
nende piirhindu ei ole vaja t=C3=B5sta. Optiliste abivahendite ja =
prilliklaaside hinnad on viimastel aastatel suurenenud ning
 praegused piirhinnad ei pruugi enam v=C3=B5imaldada sobiva abivahendi =
soetamist piirhinna ulatuses.</div>
<div>&nbsp;</div>
<div>Lisaks palume t=C3=A4psustada, millise ISO-koodi alla kuuluvad =
optilised filterklaasid. Kas neid k=C3=A4sitletakse ISO-koodi 22.03.03 =
=E2=80=9Evalgusfiltrid=E2=80=9C all? Optilised filterklaasid kuuluvad =
praegu meie hinnakirjas k=C3=B5ige kallimate toodete hulka, =
mist=C3=B5ttu soovime teada,
 kas selle abivahendi kehtiv piirhind 152 eurot paari kohta h=C3=B5lmab =
ka individuaalselt valmistatavaid optilisi filterklaase.</div>
<div>&nbsp;</div>
<div>Kui optilised filterklaasid kuuluvad nimetatud ISO-koodi alla, =
palume kaaluda ka selle piirhinna ajakohastamist vastavalt tegelikele =
turuhindadele.</div>
<div>&nbsp;</div>
<div>Lugupidamisega</div>
<div>&nbsp;</div>
<div>Liina Tarum-Maisla <br>
Eesti Optometristide Selts </div>
<div>55572374</div>
</div>
</div>
</body>
</html>

------=_NextPart_000_0037_01DD3474.D151C2B0--